ATE409684T1 - Verfahren zur herstellung der polymorphen form ii von sertralin hydrochlorid - Google Patents

Verfahren zur herstellung der polymorphen form ii von sertralin hydrochlorid

Info

Publication number
ATE409684T1
ATE409684T1 AT00975896T AT00975896T ATE409684T1 AT E409684 T1 ATE409684 T1 AT E409684T1 AT 00975896 T AT00975896 T AT 00975896T AT 00975896 T AT00975896 T AT 00975896T AT E409684 T1 ATE409684 T1 AT E409684T1
Authority
AT
Austria
Prior art keywords
producing
sertraline hydrochloride
polymorphous form
polymorphous
sertraline
Prior art date
Application number
AT00975896T
Other languages
English (en)
Inventor
Der Schaaf Paul Van
Franz Schwarzenbach
Hans-Joerg Kirner
Martin Szelagiewicz
Claudia Marcolli
Andreas Burkhard
Regine Peter
Original Assignee
Ciba Holding Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8243113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE409684(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Holding Inc filed Critical Ciba Holding Inc
Application granted granted Critical
Publication of ATE409684T1 publication Critical patent/ATE409684T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00975896T 1999-10-29 2000-10-23 Verfahren zur herstellung der polymorphen form ii von sertralin hydrochlorid ATE409684T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99810981 1999-10-29

Publications (1)

Publication Number Publication Date
ATE409684T1 true ATE409684T1 (de) 2008-10-15

Family

ID=8243113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00975896T ATE409684T1 (de) 1999-10-29 2000-10-23 Verfahren zur herstellung der polymorphen form ii von sertralin hydrochlorid

Country Status (17)

Country Link
US (2) US6872853B1 (de)
EP (1) EP1224160B1 (de)
JP (1) JP2003513062A (de)
CN (1) CN1384816A (de)
AR (1) AR026293A1 (de)
AT (1) ATE409684T1 (de)
AU (1) AU1386301A (de)
CA (1) CA2387135A1 (de)
DE (1) DE60040406D1 (de)
HU (1) HUP0203559A3 (de)
IL (2) IL149050A0 (de)
MX (1) MXPA02004255A (de)
MY (1) MY141509A (de)
TR (1) TR200201146T2 (de)
TW (1) TWI260315B (de)
WO (1) WO2001032601A1 (de)
ZA (1) ZA200203254B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1630156A1 (de) * 1998-11-27 2006-03-01 Teva Pharmaceutical Industries Ltd Polymorphe des Sertralin-Hydrochlorids
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
US20050119351A1 (en) * 1999-10-29 2005-06-02 Van Der Schaaf Paul A. Polymorphic forms of sertraline hydrochloride
US7442838B2 (en) * 1999-10-29 2008-10-28 Ciba Specialty Chemicals Corp. Polymorphic forms of sertraline hydrochloride
EP1774965A3 (de) * 1999-12-21 2007-10-10 Teva Pharmaceutical Industries Ltd Neue Sertralinhydrochloridpolymorph, Herstellungsverfahren dafür, Zusammensetzungen damit und Anwendungsverfahren
YU47902A (sh) * 1999-12-21 2005-11-28 Teva Pharmaceutical Industries Ltd. Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu
IN192343B (de) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
US7067700B2 (en) 2001-05-31 2006-06-27 Fermion Oy Process for preparing sertraline hydrochloride polymorphic form II
EP1499581A1 (de) 2002-04-29 2005-01-26 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung der polymorphen form ii von sertralinhydrochlorid, pharmazeutische formulierungen und verfahren zur deren verabreichung
CN102215522A (zh) * 2002-06-27 2011-10-12 美商内数位科技公司 宽频码分多址第一无线网络控制器
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
CA2544684A1 (en) 2003-11-04 2005-05-26 Cipla Limited Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
EP1711493A2 (de) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Kristalline formen von zolmitriptan
EP1893559A2 (de) * 2005-06-09 2008-03-05 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von sertralinhydrochlorid-form i
US7518019B2 (en) 2006-06-01 2009-04-14 Hetero Drugs Limited Processes for preparing sertraline hydrochloride crystalline forms
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
WO2012138710A2 (en) 2011-04-07 2012-10-11 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
CN105061217A (zh) * 2015-06-30 2015-11-18 徐静 枸橼酸舍曲林的2种晶型及其制备方法
EP4229164A1 (de) 2020-10-16 2023-08-23 The Procter & Gamble Company Verbraucherproduktzusammensetzungen mit mindestens zwei einkapselungspopulationen
JP7719177B2 (ja) 2020-10-16 2025-08-05 ザ プロクター アンド ギャンブル カンパニー 封入体の集団を含む消費者製品組成物
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
CN112552188B (zh) * 2020-12-17 2023-07-28 山西仟源医药集团股份有限公司 盐酸舍曲林晶型i的制备方法
CN113588626B (zh) * 2021-08-24 2024-05-24 上海师范大学 一种苯丙氨酸对映体的拉曼光谱检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
HU222341B1 (hu) 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
DE69713353D1 (de) * 1997-12-11 2002-07-18 Torcan Chemical Ltd Sertralin-Polymorph mit verbesserter Wasserlöslichkeit
CA2323629A1 (en) 1998-03-18 1999-09-23 Ciba Specialty Chemicals Holding Inc. Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
JP2000026378A (ja) 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
YU47902A (sh) 1999-12-21 2005-11-28 Teva Pharmaceutical Industries Ltd. Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu

Also Published As

Publication number Publication date
US6939992B2 (en) 2005-09-06
DE60040406D1 (de) 2008-11-13
AU1386301A (en) 2001-05-14
EP1224160A1 (de) 2002-07-24
TR200201146T2 (tr) 2004-12-21
US20040132828A1 (en) 2004-07-08
MY141509A (en) 2010-05-14
HUP0203559A3 (en) 2008-01-28
HUP0203559A2 (hu) 2003-03-28
ZA200203254B (en) 2003-07-22
IL149050A (en) 2007-03-08
MXPA02004255A (es) 2002-10-17
TWI260315B (en) 2006-08-21
CA2387135A1 (en) 2001-05-10
AR026293A1 (es) 2003-02-05
WO2001032601A1 (en) 2001-05-10
IL149050A0 (en) 2002-11-10
CN1384816A (zh) 2002-12-11
JP2003513062A (ja) 2003-04-08
EP1224160B1 (de) 2008-10-01
US6872853B1 (en) 2005-03-29

Similar Documents

Publication Publication Date Title
DE60040406D1 (de) Verfahren zur Herstellung der polymorphen Form II von Sertralin Hydrochlorid
DE59905881D1 (de) Verfahren zur herstellung von aminen
DE50000852D1 (de) Verfahren zur Herstellung von Aminen
ATE258927T1 (de) Verbessertes verfahren zur herstellung von n- substituierte aminotetraline
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69906389D1 (de) Verfahren zur herstellung von citalopram
DE50003632D1 (de) Verfahren zur herstellung von l-phenylephrinhydrochlorid
DE69803646D1 (de) Verfahren zur Herstellung der epsilon polymorphischen Form des Hexanitrohexaazaisowurtzitan
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE69925896D1 (de) Verfahren zur herstellung von schwach-löslichen aromatischen aminen
ATE262576T1 (de) Verfahren zur herstellung von weichmittelzusammensetzungen
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE60116874D1 (de) Verfahren zur herstellung von (r)-2-alkyl-3-phenyl-1-propanolen
ATA218299A (de) Verfahren zur herstellung von oxindolen
DE50005403D1 (de) Verfahren zur Herstellung von Monoisopropylamin
DE60039688D1 (de) Verfahren zur herstellung von uhrarmbandteilen
DE69916332D1 (de) Verfahren zur herstellung von etheraminalkoxylaten
DE60022565T2 (de) Verfahren zur Herstellung von Polyaminzusammensetzungen
DE50008921D1 (de) Verfahren zur herstellung von blockweichschaumpolyolen
DE60023031D1 (de) Verfahren zur herstellung von waschmitteln
DE60031231D1 (de) Verfahren zur Herstellung von 2-Alkyl-4-Isothiazolin-3-onen
DE60004119D1 (de) Verfahren zur Herstellung von Pentaacetyl-beta-D-Glucopyranose
DE50003603D1 (de) Verfahren zur Herstellung von Bistrifluormethylbenzylaminen
DE69904330D1 (de) Verfahren zur Herstellung von Amiden aus Aminen
DE60005252D1 (de) Verfahren zur Herstellung von Malononitril

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties